Alteration in tryptic peptide patterns of ferritins purified from human colon carcinoma.
Ferritin from malignant tissue differs electrophoretically from normal ferritin. The molecular basis of this difference has not yet been defined. Malignant tissue contains a mixture of ferritins from normal cells, inflammatory cells as well as cancer cells. GW-39 is a pure colon carcinoma cell system that synthesizes human carcinoembryonic antigen. Therefore, ferritin was isolated from normal colon mucosa and colon cancer tissues, as well as from the colon carcinoma cell line, to clarify the molecular relationship between normal and malignant ferritins. Colon carcinoma ferritin differs in primary structure from normal colon mucosal ferritin and contains at least six additional different tryptic peptides. These six peptides were also found in the ferritin from the colon carcinoma cell line. These data suggest that the alteration in ferritin structure occurs at the cellular level and is associated with the malignant state.
D000596:Amino Acids / Q000032:analysis; D003106:Colon / Q000032:analysis; D003110:Colonic Neoplasms / Q000032:analysis*; D005293:Ferritins / Q000302:isolation & purification; D006801:Humans; D009206:Myocardium / Q000032:analysis; D009928:Organ Specificity; D010446:Peptide Fragments / Q000032:analysis; D014357:Trypsin
D000596:Amino Acids; D010446:Peptide Fragments; D005293:Ferritins; D014357:Trypsin